Improving Adherence to Atypical Antipsychotic Agent Screening Guidelines in Pediatric Patients: A Quality Improvement Project Within an Integrated Community Mental Health Setting

Abstract

Background: Approximately 14% to 20% of children and adolescents have a mental health problem. Atypical antipsychotic agents are used to treat behavioral, emotional, and mental health problems in children and adolescents. A discrepancy between best practices and actual practices exists. Objective: The purpose of this quality improvement project was to increase adherence above baseline, through implementation of a checklist, to recommended screening guidelines in children, ages 4 to 18, prescribed atypical antipsychotic agents over 12 weeks. Design/Results: Aggregate comparison of the mean ranks of scores were tested with the Mann–Whitney U test, U = 1,087.5, n₁ = n₂ = 70, total N =140, p < .001. Variables of body mass index, blood pressure, waist circumference, fasting glucose, fasting lipids, personal history, and family history were observed and tested using the chi-square with Fisher’s exact tests and are significant at or above 99% confidence level (p < .01). Conclusion: Educating mental health providers, child and adolescent psychiatrists, and psychiatric mental health nurse practitioners on recommended screening guidelines and implementing a checklist had a measurable effect on increasing adherence to the recommended screening guidelines in a community mental health setting.

Keywords

atypical antipsychotics guideline adherence quality improvement

Get full access to this article

View all access options for this article.

References

Alexander

G. C.

Gallagher

S. A.

Mascola

Moloney

R. M.

Stafford

R. S.

(2011). Increasing off-label use of antipsychotic medications in the United States, 1995-2008. Pharmacoepidemiology & Drug Safety, 20, 177-184. doi:10.1002/pds.2082

Almandil

N. B.

Liu

Murray

M. L.

Besag

F. M.

Aitchison

K. J.

Wong

I. C.

(2013). Weight gain and other metabolic adverse effects associated with atypical antipsychotic treatment of children and adolescents: A systematic review and meta-analysis. Paediatric Drugs, 15, 139-150. doi:10.1007/s40272-013-0016-6

American Academy of Child and Adolescent Psychiatry. (2011). Practice parameters for the use of antipsychotic medications in children and adolescents. Retrieved from http://www.aacap.org/App_Themes/AACAP/docs/practice_parameters/Atypical_Antipsychotic_Medications_Web.pdf

American Diabetes Association, American Psychiatric Association, American Association of Clinical Endocrinologists, & North American Association for the Study of Obesity. (2004). Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care, 27, 596-601. doi:10.2337/diacare.27.2.596

Bauer

M. S.

(2002). A review of quantitative studies of adherence to mental health clinical practice guidelines. Harvard Review of Psychiatry, 10, 138-153. doi:10.1080/10673220216217

Borchard

Schwappach

D. L. B.

Barbir

Bezzola

(2012). A systematic review of the effectiveness, compliance, and critical factors for implementation of safety checklists in surgery. Annals of Surgery, 256, 925-933.

Chaudhary

Varma

Kapoor

Mehta

Kumaran

Nundy

(2015). Implementation of a surgical safety checklist and postoperative outcomes: A prospective randomized controlled study. Journal of Gastrointestinal Surgery, 19, 935-942. doi:10.1007/s/11605-015-2772-9

Cooper

W. O.

Arbogast

P. G.

Ding

Hickson

G. B.

Fuchs

D. C.

Ray

W. A.

(2006). Trends in prescribing of antipsychotic medications for US children. Ambulatory Pediatrics, 6, 79-83. doi:10.1016/j.ambp.2005.11.002

De Hert

Dobbelaere

Sheridan

E. M.

Cohen

Correll

C. U.

(2011). Metabolic and endocrine adverse effects of second-generation antipsychotics in children and adolescents: A systematic review of randomized, placebo controlled trials and guidelines for clinical practice. European Psychiatry, 26, 144-158. doi:10.1016/j.eurpsy.2010.09.011

10.

Funnell

Rogers

(2011). Purposeful program theory: Effective use of theories of change and logic models. San Francisco, CA: Jossey-Bass.

11.

Gill

J. S.

Tan

J. T.

Lee

H. G.

Tan

J. W.

Jawan

(2012). Adherence to metabolic guidelines in atypical antipsychotic treated subjects: Do physicians comply? African Journal of Pharmacy and Pharmacology, 6, 13-16. doi:10.5897/AJPP11.227

12.

Greenhalgh

Robert

Macfarlane

Bate

Kyriakidou

(2004). Diffusion of innovations in service organizations: Systematic review and recommendations. The Milbank Quarterly, 82, 581-629.

13.

Hales

Terblanche

Fowler

Sibbald

(2008). Development of medical checklist for improved quality of patient care. International Journal for Quality in Health Care, 20, 22-30. doi:10.1093/intqhc/mzm062

14.

Hirschler

Aranda

Calcagno

M. D. L.

Maccalini

Jadzinsky

(2005). Can waist circumference identify children with the metabolic syndrome? Archives of Pediatrics and Adolescent Medicine, 159, 740-744. doi:10.1001/archpedi.159.8.740

15.

International Diabetes Federation. (2007). The IDF consensus definition of the metabolic syndrome in children and adolescents. Retrieved from https://www.idf.org/e-library/consensus-statements/61-idf-consensus-definition-of-metabolic-syndrome-in-children-and-adolescents

16.

H. C. H.

Turner

T. J.

Finnigan

M. A.

(2011). Systematic review of safety checklist for use by medical care teams in acute hospital settings: Limited evidence of effectiveness. BMC Health Services Research, 11, 211. doi:10.1186/1472-6963-11-211

17.

Mitchell

A. J.

Delaffon

Vancampfort

Correll

C. U.

De Hert

(2012). Guideline concordant monitoring of metabolic risk in people treated with antipsychotic medication: Systematic review and meta-analysis of screening practices. Psychological Medicine, 42, 125-147. doi:10.1017/S003329171100105X

18.

Morrato

E. H.

Nicol

G. E.

Maahs

Druss

B. G.

Hartung

D. M.

Valuck

R. J.

. . . Campagna

(2010). Metabolic screening in children receiving antipsychotic drug treatment. Archives of Pediatrics and Adolescent Medicine, 164, 344-351. doi:10.1001/archpediatrics.2010.48

19.

National Research Council & Institute of Medicine. (2009). Preventing mental, emotional, and behavioral disorders among young people: Progress and possibilities. Washington, DC: National Academy of Sciences.

20.

Pappadopulos

Jensen

P. S.

Schur

S. B

MacIntyre

S. K.

II Van Orden

Sverd

. . . Rube

(2002). “Real world”: Atypical antipsychotic prescribing practices in public child and adolescent inpatient settings. Schizophrenia Bulletin, 28, 111-121. Retrieved from http://schizophreniabulletin.oxfordjournals.org/

21.

Zimmet

Alberti

K. G. M.

Kaufman

Tajima

Silink

Arslanian

, . . . IDF Consensus Group. (2007). The metabolic syndrome in children and adolescents: An IDF consensus report. Pediatric Diabetes, 8, 299-306. doi:10.1111/j.1399-5448.2007.00271.x